Biopharma News : Biopharma and Pharma news from all around the world :
- Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis
- Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases
- Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026
- MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis
- Johnson & Johnson Reaches Agreement with U.S. Government to Improve Access to Medicines and Lower Costs for Millions of Americans; Delivers on U.S. Manufacturing and Innovation Investments
- FineHeart Secures €83 Million to Support Its Growth and Establish Itself as a Future European Leader in Active Implantable Medical Devices (AIMDs)
- Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026
- GenNx360 Capital Partners Portfolio Company Nutra-Med Packaging Appoints Hany Salama as Chief Executive Officer
- Abbelight Announces Successful Series B Investment led by AVANT BIO to Accelerate Imaging Innovation and Scale Adoption Across a Broader Customer Base
- Anaergia Appoints Sasha Rollings-Scattergood as Chief Technology Officer
- EpiBiologics Closes $107M Series B to Advance Pipeline of Novel Bispecific Antibodies to Selectively Degrade Extracellular Protein Targets in Oncology and Immunology
- FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference
- Bayer and Soufflé Therapeutics Announce Strategic Collaboration to Advance Cell-Specific Heart-Targeted siRNA Therapy
- Allotex Advances from European Commercialization to U.S. Clinical Phase
- 4Moving Biotech Receives FDA IND Clearance for 4P004, Strengthening Its Position as a Leading Innovator in Disease-Modifying Osteoarthritis Therapeutics
- Organon Enters into a Commercialization Agreement for Daiichi Sankyo’s Nilemdo® in France, Denmark, Iceland, Sweden, Finland and Norway
- Azafaros to Present at J.P. Morgan’s 44th Annual Healthcare Conference
- Arrowhead Pharmaceuticals Prices Upsized Offerings of Convertible Senior Notes, Common Stock and Pre-Funded Warrants
- Novotech Appoints Anand Tharmaratnam as New CEO
- Stallergenes Greer Expands Venom Immunotherapy Production Capacity With Acquisition of Entomon s.r.l.
- RoslinCT and BOOST Pharma Announce Strategic Manufacturing Agreement to Advance Cell Therapy for Infants with Osteogenesis Imperfecta
- Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA® Commercialization in Central and Eastern Europe
- Ionis partner GSK announces positive topline results from B-Well 1 and B-Well 2 Phase 3 studies for bepirovirsen, a potential first-in-class medicine for chronic hepatitis B
- Number of Shares and Voting Rights of Innate Pharma as of December 31, 2025
- Arrowhead Pharmaceuticals Announces Proposed Offerings of Convertible Senior Notes and Common Stock
- Aptar Digital Health and ŌURA Collaborate to Advance Migraine Insights by Connecting Migraine Buddy® with Oura Ring
- Cencora Announces Date and Time for First Quarter Fiscal 2026 Earnings Release
- Exelixis to Present at the J.P. Morgan 2026 Healthcare Conference on January 12, 2026
- Nuvation Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Stoke Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
News about Biotech, Pharma, Biopharma, Medical Devices, Diagnostics, Digital Health
- Peer-reviewed study demonstrates LEON’s FR-JET® modular mixer enables stable high-concentration mRNA-LNPs with enhanced in vivo activity
- During J. P. Morgan Healthcare Week, Biotech Showcase™ Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma Partners and Media
- Fresenius Medical Care AG : Fresenius Medical Care AG is continuing its share buyback program in an accelerated manner
- VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization
- Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
- Viromed AG: Strategic Update on Operational Focus and Value Creation
- Immunic Highlights 2025 Accomplishments and Upcoming Milestones
- Newron Pharmaceuticals S.p.A.: EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan
- Pentixapharm Receives FDA Feedback for Phase 3 Diagnostic Study in Hypertension
- The Emergence of Blood Purification Devices to Treat Cardiovascular Disease
- aap successfully places a 5.7% capital increase from authorised capital at EUR 1.34, excluding subscription rights
- Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent
- Mainz Biomed Provides Review of 2025 Highlights
- O3 Holding GmbH (KD Pharma Group) acquires food-grade oil business from dsm- firmenich financed through shareholder loan
- Evotec appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
- Update on Ongoing Transactions with Pharmaceutical Company Grupo Landsteiner and the NASDAQ Listing of VERAXA Biotech AG
- Uni-Bio Science Joins Forces with WMU NERC and Ouhai District Government to Build Growth Factor Innovation Ecosystem and Accelerate Regenerative Medicine Strategy Layout
- AEVIS VICTORIA SA successfully completes major Group-wide refinancing
- FDA approves another interchangeable Ranibizumab Biosimilar, Nufymco® – Strengthening US Presence with Zydus as Commercialization Partner
- Xlife Sciences AG Announces Transition to the Main Segment of SIX Swiss Exchange to Strengthen Market Presence
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
- Gerresheimer AG: Gerresheimer AG corrects comprehensively revenues from bill-and-hold agreements
- Cantourage Group SE expects EBITDA for 2025 to exceed current market expectations based on preliminary figures
- Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt)
- Abivax to be Added to Nasdaq Biotechnology Index
- DOUGLAS Group achieves solid sales growth and doubles net income in volatile financial year 2024/25
- Correction of a release from 17/12/2025, 16:06 CET/CEST – Updated Conference Call Invitation Links
- Conference Call Invitation
- Secarna Pharmaceuticals and Protalix Biotherapeutics Enter into Collaboration and Option Agreement
- Heidelberg Pharma: Letter from the CEO
- Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis
- GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained
- MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs
- Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)
- Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026
- Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference
- Ascendis Pharma Provides Business and Strategic Roadmap Update at 44th Annual J.P. Morgan Healthcare Conference
- Cooper Aerobics Partners with The Stayton at Museum Way
- U.S. Neurology Associates Partners with M33 Growth to Transform Neurological Care
- Virbac : Declaration of the number of shares and voting rights 12/2025
- Bright Minds Biosciences Announces Closing of US$175 Million Public Offering
- Disclosure of notification received from BNP Paribas
- Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference
- Angels My Way Home Care Celebrates 15th 5-Star Google Review, Reinforcing Role as Best Home Health Care Service in Hamilton, Ontario
- SEED Therapeutics Doses First Patient in Phase 1 Trial of ST-01156, a Molecular Glue Degrader Targeting RBM39
- Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference
- Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook
- Madrigal Expands its MASH Pipeline with Exclusive Global License Agreement for Ervogastat, a Phase 2 Oral DGAT-2 Inhibitor
- Medicines360 Acquires Global Licensing Rights to Innovative Maternal Health Technologies for Risk Identification and Management Throughout Pregnancy
- NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities
- Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery
- Now Available: 1G Live Resin THCA Disposable By The Hemp Doctor
- O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated
- Allegro to start production of osteoarthritis hydrogel as it prepares for clinical trials
- Zealand Pharma enters agreement with DCAI to use Gefion AI supercomputer to accelerate drug discovery and support Metabolic Frontier 2030 strategy
- Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering
- AquaFit Weight Loss Supplement Investigation: 2026 Thermogenic Research Examines Green Tea, Berberine, and Metabolic Support Ingredients
- “Best Peptides for Hair Growth” Search Trends Surge as Telehealth Platforms Expand FDA-Approved Medication Access in 2026
- “Best Skin Tag Remover” Consumer Search Analysis: Topical Solutions vs Freezing Kits vs Clinical Procedures – NutriDerma Guard Format Overview
- True Keto Fusion Keto+ ACV Gummies: What Consumers Should Know as BHB-ACV Category Expands Into 2026
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites for more info.
Biopharma News – Pharma News